Bronchicum® Mono (Bronchicum® Mono Codein Tropfen) - Deutsch

Bronchicum® Mono Description, Presentation and Dosage

Bronchicum® Mono Description

Bronchicum® Mono Drug Class Description

Codein o. andere Morphinderivate

Bronchicum® Mono Drug Description

100 ml enth.: Codeinphosphat ½H2O 3,25 g (entspr. 2,4 g Codein-Base).

Bronchicum® Mono Generic Name

Bronchicum® Mono Codein Tropfen

Bronchicum® Mono Presentation

Bronchicum® Mono Presentation

Bronchicum® Mono Codein Tropfen

Bronchicum® Mono Manufacturer

Nattermann

Updated

01 January 2000

Bronchicum® Mono Dosage

Bronchicum® Mono Adult Dosage

Sorbitol, Pfefferminzöl, Eucalyptusöl und weitere Aromastoffe, Saccharin-Natrium, Ethanol, gereinigtes Wasser.

Bronchicum® Mono Elderly Dosage

30 Tr. (= 1 ml) entspr. 0,04 BE.

Bronchicum® Mono Precautions, Reactions and Contraindications

Bronchicum® Mono Special Precautions

Bronchicum® Mono Special Precautions

C 85 a-c

Bronchicum® Mono Adverse Reactions

Bronchicum® Mono Adverse Reactions

C 85

Related News

Phase III study of Tomtovok (Boehringer) meets endpoint for NSCLC

Read more

IDMC halts Phase III study of Vargatef (Boehringer) in NSCLC

Read more

FDA approves Tarceva (Genentech/Astellas) for NSCLC as detected by cobas EGFR Mutation Test

Read more

Merck Inc files MK 3641 at FDA for treatment of Ragweed Pollen Allergies

Read more

Ruconest (Santarus/Pharming) is re-filed with FDA for treatment of Hereditary Angioedema

Read more

Phase II study of Favorite (Activaero) shows superiority over conventional Asthma treatment

Read more

FDA approves Karbinal ER (Tris Pharma) for Allergic Rhinitis

Read more

Merck Inc. files Timothy grass pollen (Phleum pratense) allergy immunotherapy tablet at FDA

Read more

NICE rejects Xalkori (Pfizer) for treatment of Non Small Cell Lung Cancer

Read more

CRLX 101 (Cerulean Pharma) fails in Phase II trial for NSCLC

Read more

Recent Updates

Drugs

Read more

BRONCHI-PERTU® SPAG. SAFT

Read more

BROMHEXIN | -FORTE VON CT; -VON CT HUSTENSAFT

Read more

PERDIPHEN®

Read more

HUSTEN- UND FIEBER-SAFT- RATIOPHARM®

Read more

SINGULAIR® 10 MG; -JUNIOR® 5 MG

View all

Clinical Guidelines

Read more

Tuberculosis: Clinical diagnosis and management of tuberculosis, and measures for its prevention and control

Read more

Chest pain of recent onset: assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin

Read more

British Guideline on the Management of Asthma

Read more

Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease

View all

Medical Journals

Read more

Safety and efficacy of paclitaxel liposome for elderly patients with advanced non-small cell lung cancer: A multi-center prospective study

Read more

Angiopoietin 2 levels in serum and bronchial lavage fluids and their relationship with cancer stages in lung cancer patients

Read more

Influence of patient characteristics on survival following treatment with helical stereotactic body radiotherapy (SBRT) in stage I non-small-cell lung cancer

Read more

nm23-H1 gene driven by hTERT promoter induces inhibition of invasive phenotype and metastasis of lung cancer xenograft in mice

epgonline.org Social

Back to top